| 2023 |
Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database
10.1111/dom.15154
Authors: K. MedSci, V. Schnecke, C. Haase, N. Harder-Lauridsen, N. Rathor, K. Sommer, C. Morgen |
| 2023 |
Body mass index and survival in people with heart failure
10.1136/heartjnl-2023-322459
Authors: N. Jones, J. Ordonez-Mena, A. Roalfe, K. Taylor, C. Goyder, F. Hobbs, C. Taylor |
| 2023 |
Temporal trends in eating disorder and self-harm incidence rates among adolescents and young adults in the UK in the 2 years since onset of the COVID-19 pandemic: a population-based study
10.1016/s2352-4642(23)00126-8
Authors: A. Trafford, M. Carr, D. Ashcroft, C. Chew-Graham, E. Cockcroft, L. Cybulski, E. Garavini, S. Garg, T. Kabir, N. Kapur, R. Temple, R. Webb, P. Mok |
| 2023 |
Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques
10.1002/sim.9771
Authors: A. Pate, M. Sperrin, R. Riley, J. Sergeant, T. Van Staa, N. Peek, M. Mamas, G. Lip, M. O'Flaherty, I. Buchan, G. Martin |
| 2023 |
The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study
10.1016/j.amjmed.2023.06.021
Authors: H. Ayele, P. Reynier, L. Azoulay, R. Platt, J. Cabaussel, S. Benayoun, K. Filion |
| 2023 |
Pharmacologic heterogeneity and risk of severe hypoglycemia with concomitant use of sulfonylureas and DPP-4 inhibitors: population-based cohort study
10.1002/cpt.2975
Authors: J. Dimakos, Y. Cui, R. Platt, C. Renoux, K. Filion, A. Douros |
| 2023 |
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
10.3310/mnjy9014
Authors: J. Harris, K. Pouwels, T. Johnson, J. Sterne, C. Pithara, K. Mahadevan, B. Reeves, U. Benedetto, Y. Loke, D. Lasserson, B. Doble, N. Hopewell-Kelly, S. Redwood, S. Wordsworth, A. Mumford, C. Rogers, M. Pufulete |
| 2023 |
Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records
10.1186/s12877-023-04143-2
Authors: R. Joseph, R. Knaggs, C. Coupland, A. Taylor, Y. Vinogradova, D. Butler, L. Gerrard, D. Waldram, B. Iyen, R. Akyea, D. Ashcroft, A. Avery, R. Jack |
| 2023 |
Real-world evidence from the first online healthcare analytics platform-Livingstone. Validation of its descriptive epidemiology module
10.1371/journal.pdig.0000310
Authors: B. Heywood, C. Morgan, T. Berni, D. Summers, B. Jones, S. Jenkins-Jones, S. Holden, L. Riddick, H. Fisher, J. Bateman, C. Bannister, J. Threlfall, A. Buxton, C. Shepherd, E. Mathias, R. Thomason, E. Hubbuck, C. Currie |
| 2023 |
Health economic impact of moderate-to-severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data
10.1136/bmjopen-2022-067545
Authors: G. Coates, P. Clewes, C. Lohan, H. Stevenson, R. Wood, T. Tritton, R. Knaggs, A. Dickson, D. Walsh |
| 2023 |
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
10.1007/s40744-023-00566-w
Authors: H. Stirnadel-Farrant, S. Golam, B. Naisbett-Groet, D. Gibson, J. Langham, S. Langham, M. Samnaliev |
| 2023 |
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
10.1007/s40744-023-00567-9
Authors: H. Stirnadel-Farrant, S. Golam, B. Naisbett-Groet, D. Gibson, J. Langham, S. Langham, M. Samnaliev |
| 2023 |
Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink
10.1002/ski2.232
Authors: C. Kleyn, R. McKenzie, A. Meeks, B. Gittens, L. von Arx |
| 2023 |
Family adversity and health characteristics associated with intimate partner violence in children and parents presenting to health care: a population-based birth cohort study in England
10.1016/s2468-2667(23)00119-6
Authors: S. Syed, R. Gilbert, G. Feder, L. Howe, C. Powell, E. Howarth, J. Deighton, R. Lacey |
| 2023 |
Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
10.1136/openhrt-2023-002357
Authors: J. Wu, R. Nadarajah, Y. Nakao, K. Nakao, D. Hogg, K. Raveendra, R. Arbel, M. Haim, D. Zahger, C. Cowan, C. Gale |
| 2023 |
Pre-diagnostic prescribing patterns in dyspnoea patients with as-yet-undiagnosed lung cancer: A longitudinal study of linked primary care and cancer registry data
10.1016/j.canep.2023.102429
Authors: B. Wickramasinghe, C. Renzi, M. Barclay, M. Callister, M. Rafiq, G. Lyratzopoulos |
| 2023 |
Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019
10.2147/copd.s411739
Authors: P. Stone, M. Osen, A. Ellis, R. Coaker, J. Quint |
| 2023 |
Incidence of 12 common cardiovascular diseases and subsequent mortality risk in the general population
10.1093/eurjpc/zwad192
Authors: C. Prugger, M. Perier, A. Gonzalez-Izquierdo, H. Hemingway, S. Denaxas, J. Empana |
| 2023 |
Trends and patterns of antiseizure medication prescribing during pregnancy between 1995 and 2018 in the United Kingdom: A cohort study
10.1111/1471-0528.17573
Authors: P. Madley-Dowd, J. Rast, V. Ahlqvist, C. Zhong, F. Martin, N. Davies, K. Lyall, C. Newschaffer, T. Tomson, C. Magnusson, D. Rai, B. Lee, H. Forbes |
| 2023 |
The prevalent new-user design for studies with no active comparator: The example of statins and cancer
10.1097/ede.0000000000001628
Authors: S. Suissa, S. Dell'Aniello, C. Renoux |
| 2023 |
Dementia risk in patients with type 2 diabetes: Comparing metformin with no pharmacological treatment
10.1002/alz.13349
Authors: B. Zheng, B. Su, S. Ahmadi-Abhari, D. Kapogiannis, I. Tzoulaki, E. Riboli, L. Middleton |
| 2023 |
Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation
10.1093/eurheartj/ehad571
Authors: J. Wu, R. Nadarajah, Y. Nakao, K. Nakao, C. Wilkinson, J. Cowan, A. Camm, C. Gale |
| 2023 |
Age at Type 2 Diabetes Diagnosis and Cause-Specific Mortality: Observational Study of Primary Care Patients in England
10.2337/dc23-0834
Authors: M. Barker, M. Davies, J. Sargeant, J. Chan, E. Gregg, S. Shabnam, K. Khunti, F. Zaccardi |
| 2023 |
Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom
10.1111/dom.15241
Authors: W. Alkabbani, B. Shah, A. Zongo, D. Eurich, M. Alsabbagh, J. Gamble |
| 2023 |
Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection
10.1001/jamacardio.2023.2418
Authors: J. Brown, K. Wing, C. Leyrat, S. Evans, K. Mansfield, A. Wong, L. Smeeth, N. Galwey, I. Douglas |
| 2023 |
Changes to healthcare utilisation and symptoms for common mental health problems over the first 21 months of the COVID-19 pandemic: parallel analyses of electronic health records and survey data in England
10.1016/j.lanepe.2023.100697
Authors: V. Taxiarchi, M. Senior, D. Ashcroft, M. Carr, H. Hope, M. Hotopf, E. Kontopantelis, S. McManus, P. Patalay, S. Steeg, R. Webb, K. Abel, M. Pierce |
| 2023 |
Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
10.1111/add.16306
Authors: E. Domzaridou, M. Carr, T. Millar, R. Webb, D. Ashcroft |
| 2023 |
Real world safety of methoxyflurane analgesia in the emergency setting: a comparative hybrid prospective-retrospective post-authorisation safety study
10.1186/s12873-023-00862-2
Authors: N. Qizilbash, H. Kataria, H. Jarman, B. Bloom, M. Bradney, M. Oh, S. Yee, A. Roncero, I. Méndez, S. Pocock |
| 2023 |
Incidence of 'Low-Risk but Not No-Risk' Features of Cancer Prior to High-Risk Feature Occurrence: An Observational Cohort Study in Primary Care
10.3390/cancers15153936
Authors: S. Moore, S. Price, J. Bostock, R. Neal, W. Hamilton |
| 2023 |
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
10.1186/s12931-023-02523-1
Authors: A. Ismaila, K. Rothnie, R. Wood, V. Banks, L. Camidge, A. Czira, C. Compton, R. Sharma, S. Millard, O. Massey, D. Halpin |
| 2023 |
Online Survey to Investigate Asthma Medication Prescription and Adherence from the Perspective of Patients and Healthcare Practitioners in England
10.2147/jaa.s426227
Authors: X. Zhang, J. Quint |
| 2023 |
The impact of COVID-19 lockdowns on the body mass index of people living with obesity: A UK retrospective cohort study using the UK Clinical Practice Research Datalink
10.1016/j.orcp.2023.09.008
Authors: F. Zaccardi, K. Byrne, K. Khunti, D. Kloecker, R. Reynoso, S. Shabnam, L. Vaz, T. Yates, C. Gillies |
| 2023 |
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer
10.1055/a-2145-7238
Authors: A. Cohen, C. Wallenhorst, S. Choudhuri, A. Nassar, K. Pollock, C. Martinez |
| 2023 |
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification
10.1111/dme.15200
Authors: C. Pollock, J. Sanchez, J. Carrero, S. Kumar, R. Pecoits-Filho, C. Lam, H. Chen, E. Kanda, M. Lainscak, D. Wheeler |
| 2023 |
Persistent high prevalence of modifiable cardiovascular risk factors among patients with osteoarthritis in the UK in 1992-2017
10.1136/rmdopen-2023-003298
Authors: D. Yu, X. Huang, M. Mamas, R. Wilkie |
| 2023 |
Protocol for the Paediatric Otorrhoea Study (POSt): a multi-methods study to understand the burden of paediatric otorrhoea in the UK
10.1136/bmjopen-2023-078052
Authors: E. Heward, J. Dempsey, J. Lunn, J. Molloy, R. Isba, M. Carr, D. Ashcroft, A. Hay, J. Nichani, I. Bruce |
| 2023 |
Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation
10.1016/j.eclinm.2023.102213
Authors: G. Nakafero, T. Card, M. Grainge, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, D. van der Windt, M. Stevenson, R. Riley, A. Abhishek |
| 2023 |
Premature morbidity and mortality associated with potentially undiagnosed familial hypercholesterolemia in the general population
10.1016/j.ajpc.2023.100580
Authors: K. Ray, D. Pillas, S. Hadjiphilippou, K. Khunti, S. Seshasai, A. Vallejo-Vaz, D. Neasham, J. Addison |
| 2023 |
Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
10.1093/ije/dyad138
Authors: M. Català, E. Burn, T. Rathod-Mistry, J. Xie, A. Delmestri, D. Prieto-Alhambra, A. Jödicke |
| 2023 |
Obesity, metabolic health and clinical outcomes after incident cardiovascular disease: A nationwide population-based cohort study
10.1002/jcsm.13340
Authors: R. Akyea, G. Ntaios, W. Doehner |
| 2023 |
Liver function tests in patients with hypertension in primary care: prospective cohort study
10.3399/bjgpo.2023.0082
Authors: Al Harthi, P. Whiting, J. Watson |
| 2023 |
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
10.2147/copd.s408688
Authors: G. Requena, A. Czira, V. Banks, R. Wood, T. Tritton, C. Castillo, J. Yeap, R. Wild, C. Compton, K. Rothnie, F. Herth, J. Quint, A. Ismaila |
| 2023 |
Development of an Asthma Exacerbation Risk Prediction Model for Conversational Use by Adults in England
10.2147/por.s424098
Authors: C. Kallis, R. Calvo, B. Schuller, J. Quint |
| 2023 |
Long-term healthcare utilization and costs of babies bornafter assisted reproductive technologies (ART): a record linkage study with 10-years' follow-up in England
10.1093/humrep/dead198
Authors: X. Hua, O. Rivero-Arias, M. Quigley, J. Kurinczuk, C. Carson |
| 2023 |
Prevalence and demographic variation of cardiovascular, renal, metabolic, and mental health conditions in 12 million english primary care records
10.1186/s12911-023-02296-z
Authors: J. Cooper, K. Nirantharakumar, F. Crowe, A. Azcoaga-Lorenzo, C. McCowan, T. Jackson, A. Acharya, K. Gokhale, N. Gunathilaka, T. Marshall, S. Haroon |
| 2023 |
The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients with Varicella Infection: a Retrospective Cohort Analysis of Real-World Data in England
10.1093/infdis/jiad420
Authors: S. Kujawski, V. Banks, C. Casey, S. Drysdale, A. Patel, O. Massey, T. Holbrook, M. Pawaskar |
| 2023 |
The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink
10.1186/s12889-023-16768-4
Authors: A. Lophatananon, M. Carr, B. McMillan, C. Dobson, R. Itzhaki, R. Parisi, D. Ashcroft, K. Muir |
| 2023 |
Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population
10.2147/jaa.s428623
Authors: C. Kallis, A. Morgan, L. Fleming, J. Quint |
| 2023 |
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom
10.1111/dom.15196
Authors: D. Abrahami, E. D'Andrea, H. Yin, S. Kim, J. Paik, D. Wexler, L. Azoulay, E. Patorno |
| 2023 |
Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study
10.1136/thorax-2022-219757
Authors: C. Kallis, E. Maslova, A. Morgan, I. Sinha, G. Roberts, R. van der Valk, J. Quint, T. Tran |
